Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$6.10
+0.0800 ( +1.33% ) 99.2K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$6.10
Previous close
$6.02
Volume
99.2K
Market cap
$344.36M
Day range
$5.89 - $6.22
52 week range
$1.62 - $7.66
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 64 | May 09, 2024 |
| 8-k | 8K-related | 15 | May 09, 2024 |
| def | Proxies and info statements | 4 | Apr 24, 2024 |
| ars | Annual reports | 1 | Apr 24, 2024 |
| 4 | Insider transactions | 1 | Apr 12, 2024 |
| 4 | Insider transactions | 1 | Apr 12, 2024 |
| pre | Proxies and info statements | 4 | Apr 12, 2024 |
| 3 | Insider transactions | 2 | Apr 12, 2024 |
| 3 | Insider transactions | 2 | Apr 12, 2024 |
| 8-k | 8K-related | 15 | Apr 11, 2024 |